Champions Oncology (CSBR) Return on Invested Capital (2016 - 2025)
Historic Return on Invested Capital for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to 0.57%.
- Champions Oncology's Return on Invested Capital rose 48100.0% to 0.57% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.57%, marking a year-over-year increase of 48100.0%. This contributed to the annual value of 4.95% for FY2025, which is 103100.0% up from last year.
- According to the latest figures from Q4 2025, Champions Oncology's Return on Invested Capital is 0.57%, which was up 48100.0% from 0.76% recorded in Q3 2025.
- In the past 5 years, Champions Oncology's Return on Invested Capital ranged from a high of 9.85% in Q1 2024 and a low of 9.58% during Q4 2023
- In the last 5 years, Champions Oncology's Return on Invested Capital had a median value of 0.04% in 2021 and averaged 0.18%.
- Per our database at Business Quant, Champions Oncology's Return on Invested Capital crashed by -96000bps in 2023 and then soared by 102300bps in 2024.
- Quarter analysis of 5 years shows Champions Oncology's Return on Invested Capital stood at 0.05% in 2021, then plummeted by -57bps to 0.02% in 2022, then tumbled by -49347bps to 9.58% in 2023, then surged by 56bps to 4.24% in 2024, then surged by 113bps to 0.57% in 2025.
- Its Return on Invested Capital was 0.57% in Q4 2025, compared to 0.76% in Q3 2025 and 1.0% in Q2 2025.